Psyence Biomedical (PBM) Institutional Ownership $0.92 +0.02 (+2.21%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$0.96 +0.04 (+4.35%) As of 03/7/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Psyence Biomedical (NASDAQ:PBM)CurrentInstitutional OwnershipPercentage77.44%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$7.14MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.54M Get PBM Insider Trade Alerts Want to know when executives and insiders are buying or selling Psyence Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PBM Institutional Buying and Selling by Quarter Remove Ads Psyence Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 AdvisorShares Investments LLC26,923$57K0.0%-97.8%0.408% 2/14/2025 Harraden Circle Investments LLC182,323$385K0.3%N/A2.762% 2/11/2025 Virtu Financial LLC12,692$27K0.0%N/A0.192% 2/10/2025 Essential Planning LLC.73,278$163K0.0%N/A1.110% 8/8/2024 AdvisorShares Investments LLC463,042$148K0.0%+70.7%5.269% 5/20/2024 Virtu Financial LLC26,419$30K0.0%N/A0.301% (Data available from 1/1/2016 forward)Remove Ads PBM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBM shares? During the previous two years, the following institutional investors and hedge funds held shares of Psyence Biomedical shares: Harraden Circle Investments LLC ($385K), Essential Planning LLC. ($163K), and AdvisorShares Investments LLC ($57K), Virtu Financial LLC ($27K).Learn more on PBM's institutional investors. What percentage of Psyence Biomedical stock is owned by institutional investors? 77.44% of Psyence Biomedical stock is owned by institutional investors. Learn more on PBM's institutional investor holdings. Which institutional investors have been buying Psyence Biomedical stock? The following institutional investors have purchased Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($191.71K), Harraden Circle Investments LLC ($182.32K), Essential Planning LLC. ($73.28K), and Virtu Financial LLC ($39.11K). How much institutional buying is happening at Psyence Biomedical? Institutional investors have bought a total of 486,418 shares in the last 24 months. This purchase volume represents approximately $7.14M in transactions. Which Psyence Biomedical major shareholders have been selling company stock? The following institutional investors have sold Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($1.21M). How much institutional selling is happening at Psyence Biomedical? Institutional investors have sold a total of 1,205,453 shares in the last 24 months. This volume of shares sold represents approximately $2.54M in transactions. Related Companies Q32 Bio Major Shareholders Passage Bio Major Shareholders Pulmatrix Major Shareholders Celularity Major Shareholders CEL-SCI Major Shareholders ProMIS Neurosciences Major Shareholders Equillium Major Shareholders DURECT Major Shareholders Cyclo Therapeutics Major Shareholders Finch Therapeutics Group Major Shareholders This page (NASDAQ:PBM) was last updated on 3/9/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.